AfroCentric Investment Corporation Limited (AfroCentric Group) is a Black-owned, JSE-listed investment holding company with a primary focus on the healthcare and complementary financial services sectors. Its portfolio includes prominent South African entities like Medscheme, an administrator of medical schemes, and pharmaceutical businesses such as Activo Health and Pharmacy Direct. The group aims to enhance access to quality healthcare and financial services, driving transformation and sustainable value for its stakeholders across Africa.
Serves as the corporate center for strategic oversight, financial management, investment decisions, and governance for all Afrocentric Group subsidiaries and operations.
Modern corporate office facilities located in a key commercial district, designed to support efficient operations and collaboration among its various divisions.
The work culture at Afrocentric Group's headquarters is characterized by professionalism, a strong focus on ethical conduct, innovation in healthcare solutions, and a commitment to transformation and empowerment within South Africa.
The Johannesburg headquarters is pivotal for Afrocentric Group's operations, placing it in South Africa's economic heartland, facilitating engagement with key industry stakeholders, regulatory bodies, and the financial community. It's central to managing its JSE-listed status.
Afrocentric Group's primary operational presence is in South Africa, where most of its subsidiaries are based and conduct their core business. The group also has a presence in other African countries, including Botswana, Namibia, Eswatini, Kenya, and Zimbabwe, primarily through its Medscheme subsidiary and associated healthcare administration services. Their strategy includes exploring further expansion opportunities across the African continent.
37 Killarney Road, Killarney
Johannesburg
Gauteng
South Africa
Address: Multiple locations through subsidiaries like Medscheme, Activo Health, and Pharmacy Direct.
These locations support the direct delivery of healthcare administration, pharmaceutical distribution, and related services to clients and members across South Africa.
Address: Medscheme Botswana offices
Serves the Botswanan market with localized healthcare administration solutions, adapting the group's expertise to regional needs.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, AfroCentric Group' leadership includes:
AfroCentric Group has been backed by several prominent investors over the years, including:
Afrocentric Group has maintained a relatively stable executive team over the past year, with a focus on strategic execution. No major high-profile executive hires or exits have been widely publicized in the last 12 months, indicating continuity in leadership.
Discover the tools AfroCentric Group uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Afrocentric Group and its subsidiaries like Medscheme commonly use professional email formats. The most prevalent format typically combines the first initial and last name, or full first name and last name, with the company domain.
[firstinitial][lastname]@afrocentric.za.com or [firstname].[lastname]@afrocentric.za.com. For subsidiaries like Medscheme, it would be @medscheme.co.za
Format
abanderker@afrocentric.za.com or ahmed.banderker@afrocentric.za.com
Example
80%
Success rate
Afrocentric Group Website / SENS • February 28, 2024
Afrocentric Group announced its interim financial results, highlighting revenue growth and performance across its healthcare and pharmaceutical divisions. The company reported a 7.5% increase in Group revenue to R5.1 billion and a 12.9% rise in profit after tax to R326.9 million. The results underscored the resilience of its business model despite challenging economic conditions....more
Afrocentric Group Website / SENS • September 20, 2023
Afrocentric Group released its audited financial results for the year ended June 30, 2023. The company showcased steady performance, emphasizing growth in its services division and expansion initiatives. Key highlights included increased membership in administered medical schemes and growth in pharmaceutical distribution....more
Engineering News • August 1, 2023
While not directly related to its core healthcare business, AfroCentric, through its subsidiary Chef Direct (part of the Services cluster), commented on the Competition Commission's Fresh Produce Market Inquiry report, indicating its interest in fair market practices that could impact its food services operations linked to institutional catering....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including AfroCentric Group, are just a search away.